Cardax, Inc.
CDXIOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$80
P/E Ratio—
52W High$0.004
52W Low$0.000001
Cardax, Inc. (CDXI) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CDXI · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2021Report Date: May 14, 2021EPS Actual
-$1.74
Revenue
$0.00B
Fiscal Period
Q2 FY2021
FY ends December
Report Date
May 14, 2021
After Market Close
CDXI reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q2 FY2021 | May 14, 2021 | — | -$1.74 | — | $0.00B | — | — |
| — Q4 FY2020 | Dec 31, 2020 | — | -$1.79 | — | $0.00B | — | — |
| — Q4 FY2020 | Nov 13, 2020 | — | -$1.79 | — | $0.00B | — | — |
| — Q3 FY2020 | Aug 14, 2020 | — | -$2.26 | — | $0.00B | — | — |
| — Q2 FY2020 | May 15, 2020 | — | -$1.43 | — | $0.00B | — | — |
| — Q4 FY2019 | Dec 31, 2019 | — | -$2.10 | — | $0.00B | — | — |
| — Q4 FY2019 | Nov 14, 2019 | — | -$2.00 | — | $0.00B | — | — |
| — Q3 FY2019 | Aug 14, 2019 | — | -$2.00 | — | $0.00B | — | — |
Q2 FY2021
May 14, 2021
EPS Actual
-$1.74
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2020
Dec 31, 2020
EPS Actual
-$1.79
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2020
Nov 13, 2020
EPS Actual
-$1.79
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2020
Aug 14, 2020
EPS Actual
-$2.26
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2020
May 15, 2020
EPS Actual
-$1.43
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2019
Dec 31, 2019
EPS Actual
-$2.10
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2019
Nov 14, 2019
EPS Actual
-$2.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2019
Aug 14, 2019
EPS Actual
-$2.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
No analyst estimates available for CDXI.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2021 | May 14, 2021 | — | $1.75 | $2.00 | +14.29% |
| — Q4 FY2020 | Dec 31, 2020 | — | $1.65 | $1.70 | +3.03% |
| — Q4 FY2020 | Nov 13, 2020 | — | $1.74 | $1.74 | +0.00% |
| — Q3 FY2020 | Aug 14, 2020 | — | $4.01 | $4.00 | -0.25% |
| — Q2 FY2020 | May 15, 2020 | — | $9.75 | $9.75 | +0.00% |
| — Q4 FY2019 | Dec 31, 2019 | — | $10.77 | $10.15 | -5.72% |
| — Q4 FY2019 | Nov 14, 2019 | — | $12.00 | $12.00 | +0.00% |
| — Q3 FY2019 | Aug 14, 2019 | — | $20.42 | $20.40 | -0.10% |
Q2 FY2021+14.29%
Report Date
May 14, 2021
EPS Beat/Miss
—
Price Before
$1.75
Price After
$2.00
Q4 FY2020+3.03%
Report Date
Dec 31, 2020
EPS Beat/Miss
—
Price Before
$1.65
Price After
$1.70
Q4 FY2020+0.00%
Report Date
Nov 13, 2020
EPS Beat/Miss
—
Price Before
$1.74
Price After
$1.74
Q3 FY2020-0.25%
Report Date
Aug 14, 2020
EPS Beat/Miss
—
Price Before
$4.01
Price After
$4.00
Q2 FY2020+0.00%
Report Date
May 15, 2020
EPS Beat/Miss
—
Price Before
$9.75
Price After
$9.75
Q4 FY2019-5.72%
Report Date
Dec 31, 2019
EPS Beat/Miss
—
Price Before
$10.77
Price After
$10.15
Q4 FY2019+0.00%
Report Date
Nov 14, 2019
EPS Beat/Miss
—
Price Before
$12.00
Price After
$12.00
Q3 FY2019-0.10%
Report Date
Aug 14, 2019
EPS Beat/Miss
—
Price Before
$20.42
Price After
$20.40
Beat Rate0 / 8 quarters
Largest Move+14.29% (Q2 FY2021)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CDXI ends December
Cardax, Inc. (CDXI) most recently reported earnings on May 14, 2021 for Q2 FY2021, posting EPS of $-1.74 (in line with the analyst consensus of —). The next CDXI earnings date is expected around September 1, 2026.
Each quarter, investors track CDXI earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CDXI revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CDXI's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CDXI earnings · 4 questionsCardax, Inc.'s next earnings report is expected around September 1, 2026. CDXI typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CDXI historically reports after market close (AMC).
CDXI earnings datewhen is CDXI earningsCDXI next earnings datewhen does CDXI report earningsCDXI earnings calendar
▸ Source: FMP · Cardax, Inc. SEC filings · US GAAP · Cardax, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026